GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
61.18
+0.31 (0.51%)
At close: Feb 18, 2026, 4:00 PM EST
61.45
+0.27 (0.44%)
After-hours: Feb 18, 2026, 7:21 PM EST

GSK Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
115,91498,52168,78675,29570,343108,945
Market Cap Growth
63.81%43.23%-8.64%7.04%-35.43%19.45%
Enterprise Value
134,734117,42884,17592,66787,835147,418
Last Close Price
61.1849.0432.4334.2131.2038.21
PE Ratio
15.0712.8121.3412.003.9018.35
PS Ratio
2.642.241.751.951.993.26
PB Ratio
5.404.594.204.625.783.77
P/FCF Ratio
13.4411.4510.6610.849.3311.49
P/OCF Ratio
11.139.468.388.737.8910.12
EV/Sales Ratio
3.062.672.142.402.494.41
EV/EBITDA Ratio
7.586.618.097.067.8414.04
EV/EBIT Ratio
10.619.2510.878.669.9619.32
EV/FCF Ratio
15.6213.6513.0413.3411.6515.55
Debt / Equity Ratio
1.111.111.301.412.081.13
Debt / EBITDA Ratio
1.341.341.991.722.223.12
Debt / FCF Ratio
2.772.773.303.303.353.45
Net Debt / Equity Ratio
0.900.900.970.961.220.90
Net Debt / EBITDA Ratio
1.081.081.521.201.322.48
Net Debt / FCF Ratio
2.242.242.462.261.962.74
Asset Turnover
0.540.540.530.510.420.31
Inventory Turnover
1.541.541.581.581.721.36
Quick Ratio
0.520.520.500.600.660.53
Current Ratio
0.820.820.780.890.910.79
Return on Equity (ROE)
43.31%43.31%22.80%46.38%31.31%16.68%
Return on Assets (ROA)
9.78%9.78%6.53%8.82%6.57%4.41%
Return on Invested Capital (ROIC)
26.51%28.62%20.63%30.98%20.35%13.48%
Return on Capital Employed (ROCE)
23.70%23.70%16.40%22.10%19.60%10.20%
Earnings Yield
6.64%7.81%4.69%8.34%25.62%5.45%
FCF Yield
7.44%8.73%9.38%9.23%10.72%8.70%
Dividend Yield
2.74%1.81%2.35%2.16%2.37%3.54%
Payout Ratio
89.69%44.86%94.91%45.60%23.18%91.20%
Buyback Yield / Dilution
0.60%0.60%-0.75%-0.66%-0.79%-0.55%
Total Shareholder Return
3.34%2.42%1.60%1.50%1.58%3.00%
Updated Feb 4, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q